Study Summary
This trial will assess if a 12-week intervention of time-restricted eating, or TRF, could help reduce cancer-related fatigue. Participants will be randomly assigned to either the TRF intervention or a control group. The TRF group will select an 10-hour window to consume all food and beverages. The study will also explore if there is a relationship between fatigue, circadian rhythm, and glucose metabolism.
- Therapies
- Diet Therapy
- Time
- Tumors
- Intermittent Fasting
- Fatigue
- Survivorship
- Time-Restricted Feeding
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: 12 weeks
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Time-restricted eating
1 of 1
Experimental Treatment
30 Total Participants · 1 Treatment Group
Primary Treatment: Time-restricted eating · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is recruitment still open for this research program?
"According to clinicaltrials.gov, this particular medical trial is currently seeking qualified participants. It was originally made available on November 1st 2022 and the information has been recently updated on November 15th, 2022." - Anonymous Online Contributor
What is the enrollment size for this research endeavor?
"Affirmative. Clinicaltrials.gov data implies that this trial is actively recruiting participants, who were first sought after on November 1st 2022 and was most recently updated on the 15th of November 2022. 30 patients are required at a single medical centre for its completion." - Anonymous Online Contributor